Lawrence E. Flaherty, MD
Barbara Ann Karmanos Cancer Institute
3
0
3
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Show-Li Sun, MD
Astex Pharmaceuticals, Inc.
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Antoni Ribas, MD
Jonsson Comprehensive Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Jeffrey A. Sosman, MD
Vanderbilt-Ingram Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Ralph Hauke, MD
University of Nebraska
Shared therapeutic areas:
Worked with same sponsors:
Jeffrey S. Weber, MD, PhD
University of Southern California
Shared therapeutic areas:
Worked with same sponsors:
Ulka N. Vaishampayan, MD
Barbara Ann Karmanos Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Thomas F. Gajewski, MD, PhD
University of Chicago
Shared therapeutic areas:
Worked with same sponsors:
Lauren E. Abrey, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
John A. Glaspy, MD, MPH
Jonsson Comprehensive Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
All 3 trials loaded